Bills: SJR36, SJR2, SB4, SR45, SR47, SR63, SR66, SR70, SR85, SCR14, SB10, SB11, SB10, SB11

Keywords: SJR 2, Senate Joint Resolution 2, constitutional amendment, homestead exemption, property tax relief, school property tax, ad valorem tax, residence homestead, school district taxes, Texas Constitution Article VIII, public school finance, homeowner exemption, elderly exemption, senior tax relief, disabled exemption, tax year 2025, voter approval, November 2025 ballot, local government, Ways & Means

Transcript Highlights:

• And I'm still looking for a little bit more precise answer, Madam Secretary. Did they say...
• Looking for a little bit more precise answer, Madam Secretary.
• School of Medicine to provide faculty supports and tuition supports for medical students.
• Just real quick, back to page 26, line 284 for the School of Medicine. I'm all in.
• Chair and Senator, this is only a piece of that School of Medicine cost.

Bills: SB193, SB132, SB35, SB145

Keywords: SB193, acequia, community ditch, irrigation works construction fund, water infrastructure, ditch infrastructure, irrigation, New Mexico water law, agricultural water, farmers, Rio Grande, acequia association, forest land protection revolving fund, state fund transfer, irrigation projects, SB132, DOIT, Department of Information Technology, software replacement, equipment replacement

Transcript Highlights:

• Texas Southern University, and Baylor College of Medicine.
• And this has expanded beyond our work in nurturing... degenerative disease as well as precision medicine
• Fertitta Family College. of Medicine.
• , and veterinary medicine.
• and veterinary medicine.

Keywords: 1184, house, all

Transcript Highlights:

• I think then the solution would be to narrow and clarify that it's simply the precise phrase.
• I think then the solution would be to narrow and clarify that it's simply the precise phrase.
• I think then the solution would be to narrow and clarify that it's simply the precise phrase.
• I think then the solution would be to narrow and clarify that it's simply the precise phrase.
• It's simply the precise phrase.

Keywords: 912, senate, all

Summary: On the deferred agenda, the Committee on Public Safety and Military Affairs took up SB 1364, which makes emergency appropriations for law enforcement personnel costs, and SB 1452, which relates to the Uniform Controlled Substances Act. The chair recommended both measures pass with amendments, including technical corrections and a committee-report effective date of July 1, 2077. For SB 1364, the amendments included specified general fund and transfer fund amounts for DAGS, the Judiciary, and the Department of Law. For SB 1452, the chair said the bill was being corrected to fix a drug-name error that had been replicated from a federal mistake. Both recommendations were adopted by vote, with Senator Dort excused. The committee then discussed SB 1612, a joint measure on fitness to proceed that would require and appropriate funds for a five-year pilot program involving the Department of Corrections and Rehabilitation and the Department of Health, with interim and final reports to the Legislature. Testimony was mixed: the Judiciary and Department of Health were supportive, while the Office of the Public Defender and the Disability Rights Center opposed it, arguing it conflicted with best practices and the Clark consent order, and that people found not fit to proceed must be sent to the state hospital. DCR said its main concern was that the bill would still require patients to be housed in its facilities, which it said are not rehabilitative and are already strained by staffing shortages and limited access. The bill’s author argued the proposal was meant to create joint custody and reduce the high cost of state-hospital placement, but the committee did not take final action in the portion provided. In the joint hearing with Health and Human Services, the committees heard SB 1322, a broad rewrite of the state mental health code. The Attorney General supported the measure as a comprehensive cleanup and modernization effort, but many testifiers raised concerns. Queen’s Health System and Hawaii Health Systems Corporation supported the concept but warned about emergency-room impacts and asked for amendments; IHS supported the bill with a caveat about assisted community treatment procedures; and the Public Defender, Disability Rights Center, and others opposed parts of it, citing due process, privacy, HIPAA, counsel rights, liability immunity, and the reduction of an involuntary-treatment panel from three clinicians to one psychiatrist. The hearing also covered SB 951 on child protection, where the Department of Defense supported the bill and proposed technical amendments and MOUs with military components to clarify reporting and coordination procedures; DHS and the Attorney General said they were still working through possible changes. Finally, SB 228 on excited delirium was heard, with the Public Defender and Disability Rights Center supporting the bill and arguing the term has been misused and that better police de-escalation training is the real solution.

Transcript Highlights:

• medicine and improving human health.
• Mark Diaz, clinical professor, UC Davis School of Medicine, in support.
• My name is Mark Diaz, clinical professor, UC Davis School of Medicine, in support. Thank you.
• Hi, Barton Wise, professor of medicine at UC Davis School of Medicine, and I strongly support the bill
• I'm a medical student at the UC Davis School of Medicine, and I strongly support this bill.

Keywords: 988, house, all

Transcript Highlights:

• We are now pioneering the kind of precision approaches that made such a difference in cancer treatment
• However, I'm also an internal medicine physician and a professor of medicine at the Texas Tech University
• The term in medicine is "preserving morbidity."
• By way of introduction, I recently joined the Department of Neurology at Baylor College of Medicine.
• Huda Sogbe at Baylor College of Medicine.

Bills: SB5, SJR3, SB 5, SJR 3

Keywords: dementia, research institute, Alzheimer's disease, Parkinson's disease, funding, grants, state health initiatives, research funding, state budget, prevention, healthcare, medical research, Dementia Prevention and Research Institute, disaster relief, flood preparedness, emergency funding, local government support, meteorological forecasting, district apportionment, legislative rules

Transcript Highlights:

• </c><00:33:24.159><c> what</c> charlatan and that is precisely what charlatan and that is precisely what
• We want to make sure that every patient who relies upon that system in order to get the medicine they
• We want to make sure that every patient who relies upon that system in order to get the medicine they
• We want to make sure that every patient who relies upon that system in order to get the medicine they
• Representative Stevenson. ...in order to get the medicine they need is able to do so.

Keywords: 1183, house

Transcript Highlights:

• that you'll continue to explore some of these issues and try to assure that we're getting this as precise
• . ...you'll continue to explore some of these issues and try to assure that we're getting this as precise
• ensure that the... ...forward, they can just use the urban water management plan to ensure that the precise
• And so precisely because we don't want to have to try to reach north and to reach to all these other
• From biotechnology to medicine, agriculture, climate, AI, and beyond, California is the global leader

Summary: The committee first heard SB 1135, which would reestablish the California Wildlife Coexistence Program to promote nonlethal human-wildlife conflict reduction and support coexistence efforts for species such as wolves, bears, and mountain lions. Supporters, including wildlife groups and local government representatives, said the prior program was effective and that proactive tools like fladry, guardian animals, deterrents, reporting, and outreach reduce conflicts and costs. Ranching and agricultural groups were opposed unless amended, saying they supported the concept but wanted changes to the wolf-livestock compensation program, including clearer practicability standards, protection of compensation funds, and more flexibility on nonlethal requirements. The bill was moved to Appropriations on a 2-0 vote, with the measure left on call. The committee then took up SB 1085, which would preserve water supply assessments for large development projects even when those projects are exempt from CEQA, so local agencies still receive information about whether sufficient water exists for the project. The author and sponsor argued the bill would keep water planning and land use planning linked and prevent “paper water” problems, while the California Building Industry Association opposed it, warning it could add delay, uncertainty, and litigation risk for housing projects already subject to other water-supply safeguards. Members discussed how the bill would affect different local structures, especially cities that also operate their own water systems, and whether the assessment adds value in those cases. The bill passed 4-1 to Local Government and was left on call. SB 1270 was next, expanding the California wildfire mitigation home-hardening pilot beyond the original six counties to include four additional high-risk counties identified by Cal OES and Cal Fire, and directing future funding toward those areas. Supporters said the recent Los Angeles fires showed the need to broaden access to home-hardening assistance, while members discussed whether the program should remain geographically targeted or be made available statewide based on need. The bill was amended in committee and passed 5-0 to Emergency Management, left on call. Finally, the committee heard SB 895, a major proposal to place a $23 billion bond on the ballot to create a California Foundation for Science and Health Research and stabilize scientific research funding in the state. The author, UC, UAW, and many research, labor, health, and university groups supported the measure, arguing that federal cuts and instability threaten California’s research workforce, innovation, and economy. Some members raised concerns about the size of the bond and about political issues involving one sponsor, but the author said the foundation would operate under California law and the bill is intended to keep science funding open and collaborative. The bill was moved out of committee on a 5-0 vote and left on call.

Transcript Highlights:

• It’s not precise, and it will not stand a challenge, which we are in the process of making to that law
• It's not precise and it does It's vague.
• Everything came back to, you know, food is medicine. A bottom line was a mantra for us.
• Everything came back to, you know, food is medicine. A bottom line was a mantra for us.
• Uh uh the food is medicine resolution.

Keywords: 00:00 - Call to Order/Roll Call 01:27 - Discussion of 26RS HB 470 29:05 - Roll Call Vote on 26RS HB 470 32:06 - Discussion of 26RS HJR 25 34:49 - Roll Call Vote on 26RS HJR 25 37:08 - Adjournment, 958, all

Transcript Highlights:

• medicine and improving human health.
• And that research exists in new forms of medicine and new discoveries and quantum computing and all these
• My name is Mark Diaz, clinical professor, UC Davis School of Medicine, in support. Thank you.
• I'm a professor of medicine at UC Davis School of Medicine, and I strongly support the bill.
• I'm a medical student at the UC Davis School of Medicine, and I strongly support this bill.

Summary: The Assembly Appropriations Committee met on June 24, 2026, but initially lacked a quorum and began by hearing presentations only. SB 308 was presented as a bill to streamline fiscal reporting for California community colleges by combining two overlapping annual audit reports into one. SB 895, the California Science and Health Research Bond, drew extensive testimony from the authors and many supporters, who argued it would help offset federal research cuts, protect California’s science infrastructure, support jobs, and preserve life-saving research in areas such as cancer, HIV, Parkinson’s, ALS, climate resilience, and quantum computing. The bill was described as a bond measure that would require a three-party agreement and was sent to suspense. After quorum was established, the committee took up the consent and suspense calendars. Several bills were approved on consent, including SB 308 and a large group of other measures, while the suspense calendar was deemed approved, including SB 895 and other bills listed by the chair. Public comment on SB 895 continued for a long period, with many researchers, students, labor representatives, university officials, and patient advocates speaking in strong support and urging the bill be moved to the floor. The committee also heard SB 1350, which would expand green hydrogen by allowing renewable portfolio standard credits for certain hydrogen use in power generation; the author and supporters said it would help clean energy development, create jobs, and support projects like ARCHES and Element. Later, SB 1306 was presented to align California law with federal exemptions for certain chemical mixtures containing GBL used in semiconductor manufacturing research. The author and SEMI’s representative said the bill would reduce unnecessary regulatory burdens, avoid disrupting semiconductor supply chains, and not change rules for pure GBL. The bill passed out of committee on a roll call vote, with one no vote and one not voting. The hearing then adjourned.

Transcript Highlights:

• Gegbe is a board-certified family medicine physician and has over a decade of experience.
• She earned her Doctor of Medicine from Ross University and completed her family medicine residency at
• , and correctional medicine.
• Her clinical interests focus on preventative medicine. And patient education.
• Consideration, and precision.

Bills: SB27, SB30, SB293, HB4, HB2974, HB5138, SJR36, SJR50, SJR63, SCR12, SCR39, SB2023, SB62, SB666, SB847, SB284, SB854, SB810, SB1505, SB583, SB507, SB1434, SB1772, SB2016, SB1122, SB731, SB397, SB508, SB1436, SB287, SB1882, SB393, SB1791, SB209, SB2429, SB1085, SB1975, SB2717, SB1262, SB636, SB2056, SB884, SB1200, SB1845, SB2458, SB801, SB3014, SB3013, SB758, SB2797, SB2076, SB2876, SB1640, SB1449, SB1181, SB1234, SB2926, SB2841, SB1528, SB1854, SB317, SB1250, SB2082, SB1237, SB2819, SB629, SB2608, SB1602, SB2009, SB867, SB640, SB1698, SB2680, SB913, SB1071, SB1086, SB1087, SB1483, SB1444, SB1553, SB1556, SB1703, SB2133, SB2297, SB2298, SB2622, SB2955, SB2334, SB1367, SB2044, SB2363, SB2565, SB1888, SB3036, SB3057, SB3043, SB3063, SB3035, SB203, SB2688, SB2522, SB2459, SB2655, SB2251, SB1884, SB2928, SB2566, SB2549, SB2553, SB2919, SB1944, SB1232, SB1798, SB2603, SB2607, SB2683, SB1319, SB3045, SB3071, HB796, HB1523, HB5294, HB748, HB3395, HB180, HB3171, HB146, HB5596, HB5694, HB1135, HB3225, HB186, HB1449, HB3793, HB112, HB104, HB3336, HB3520, HB3320, HB5663, HB2399, HB111, HB3483, HB4580, HB3748, HB632, HB4730, HB5690, HB5689, HB3385, HB4359, HB5381, HB123, HB5606, HB1057, HB3664, HCR141, HCR40, HCR59

Keywords: judicial conduct, judges discipline, judicial compensation, retirement benefits, judicial transparency, SJR 50, constitutional amendment, Texas Constitution, Article VIII, securities tax, transaction tax, occupation tax, financial markets, broker-dealer, stock exchange, securities exchange, trading platform, clearing agency, transfer agent, FINRA

Transcript Highlights:

• And if it has AI included, it goes into this deeper dive looking at performance, accuracy, precision,
• I'm a practicing internal medicine physician.
• When I practice medicine, I don't know how to read a CBC myself.
• When I practice medicine, I don't know how to read a CBC myself.
• So this is actually how I think precision medicine was supposed to look, delivered by AI in a way that's

Summary: The joint informational hearing of the Assembly Health and Privacy Committees focused on generative AI in health care, with opening remarks emphasizing both its potential to improve care and its risks around privacy, bias, liability, workforce impacts, and unequal access. Chair Bauer-Kahan and Chair Bonta framed the discussion around how California can encourage beneficial innovation while protecting patients, especially given the sensitivity of health data and the possibility that AI could worsen existing disparities if not carefully governed. The first panel featured representatives from Cedars-Sinai, Kaiser Permanente, Penguin AI, and Google, who described current uses of AI such as ambient clinical scribes, nursing documentation tools, imaging triage, maternal-fetal risk prediction, and administrative automation. Speakers said these tools can reduce clinician burden, improve patient experience, speed treatment, and in some cases improve outcomes, including a reported mortality benefit from a Kaiser predictive model and faster thrombectomy times at Cedars-Sinai. Members raised concerns about accuracy with accents and multilingual visits, whether predictive tools could reinforce bias or lead to more interventions such as C-sections, and how to ensure a human remains in the loop for important decisions. The second panel, including representatives from the California Health Care Foundation, UC Berkeley, and Stanford, focused on policy and governance challenges. Testimony highlighted examples of AI supporting homelessness outreach and community health work, but also warned that biased algorithms can encode inequities, especially when trained on data that reflect under-treatment of Black, rural, or low-income patients. Witnesses urged clearer standards for trustworthy AI, stronger monitoring and governance structures, better data access for accountability, and attention to the safety net’s limited resources. Several speakers argued that states should require health systems to have AI governance processes, clarify liability between developers and deployers, and regulate downstream uses of AI while preserving access to data for lifesaving research and oversight.

Transcript Highlights:

• I actually know... ...precisely what it is, but do you want to include dual credit students?
• I actually know precisely what it is, but do you want to include dual credit students?
• Precision ag and precision ag tech are two programs that are continually expanding.
• With the help of the legislature, we also have, and donations, we've expanded that precision ag and precision
• Most likely, the School of Medicine is going to make them... ...dual credit or AP biologies.

Summary: The committee reconvened at North Dakota State College of Science for a presentation from President Dr. Flanagan and college leaders about NDSCS’s mission, enrollment growth, workforce training, and facilities needs. Flanagan highlighted student success in national competitions, strong placement and retention, growing enrollment, and new or expanding programs in aviation maintenance, fire science, dental hygiene, community health worker training, surgical technology, HVAC/plumbing, and precision agriculture. He also emphasized the college’s partnerships with industry, including John Deere, Fargo Jet Center, Sanford, and Comdel Innovation, and said NDSCS plans to seek approval next session for a revenue bond to build a new dorm and to remodel the library into academic and allied health space. Allied health dean Deb Smith testified that her division is at capacity and needs a simulation center, more lab and classroom space, and expanded dental and OTA facilities to meet demand and accreditation needs. Committee members questioned Flanagan and staff about workforce shortages, especially faculty pay, and whether the college can staff additional growth. Flanagan said the biggest challenge is recruiting instructors because industry pays more, but noted some health care and adjunct hiring is possible because of schedule flexibility and benefits. He also discussed shifting resources away from lower-demand programs like power sports toward higher-demand areas such as automotive and aviation maintenance. Members also asked about the college’s identity as a technical institution, with Flanagan arguing North Dakota would benefit from a more defined tech-school system. The committee then received a University System presentation from Jamie Wilkie on the cost of delivering dual credit. Wilkie explained the methodology used to allocate direct and overhead costs across subsidized and unsubsidized dual credit, noting that dual credit and early entry account for about 5.9% of total credit hours and 2.7% of formula funding. The analysis showed subsidized dual credit tuition revenue of about $5.5 million and unsubsidized revenue of about $2.9 million, with some institutions showing margins and others losses depending on the model. Members discussed whether K-12 funding should also be reflected, how payments to high schools and teachers are structured, and whether tuition-free dual credit would require replacing both tuition revenue and the current dual credit scholarship. No votes were taken; the committee simply received the presentations and discussed the findings.

Transcript Highlights:

• the original machine learning-enabled Ion technology, which uses the patient's own scans to map a precise
• to use the ultra-thin catheter you see there to take a precise biopsy without excessive trauma to the
• So really, in our $4.2 trillion economy in the state, this is actually a precision instrument.
• So really, in our $4.2 trillion economy in the state, this is actually a precision instrument.
• And we can be the state that... economy in the state, this is actually a precision instrument.

Summary: The Assembly Select Committee on Biotechnology and Medical Technology held a hearing on California’s medical technology landscape, with opening remarks emphasizing the sector’s size, economic impact, and role in jobs and innovation. The first panel contrasted MedTech with biopharma, describing MedTech as hardware- and manufacturing-oriented, more incremental in development, and more dependent on supply chains, land use, and mid-skilled workforce pipelines. Witnesses argued California is the epicenter for MedTech because of its mix of engineering, software, hospitals, and manufacturing ecosystems, and cited clusters in places like Irvine, Fremont, Carlsbad, and the Bay Area. They also highlighted examples such as Penumbra and Vyaire Medical Systems to show how local manufacturing, community college training, and reshoring can support growth. The panel discussed cybersecurity, trade relations, supply chain disruptions, and the need for better coordination with hospitals and regulators, while AdvaMed stressed that medical devices are already heavily regulated by the FDA and should generally be exempt from broader state laws that could create a patchwork of requirements. Members also discussed AI in MedTech, workforce training, and the possible effects of federal NIH funding cuts, with witnesses saying MedTech is less dependent on NIH than biopharma but still benefits from a strong innovation ecosystem. Committee members then asked about AI, affordability, patient satisfaction, women’s health, and the R&D tax credit. Witnesses said AI is helping reduce errors, redundant testing, and imaging time, while keeping clinicians in the loop, and that digital pathology and robotic surgery are improving diagnosis and treatment. They also noted that packaging, plastics, and recycling can affect FDA approvals, and that FemTech is an active and growing area for investment and acquisition. Several members raised concerns about California’s regulatory and incentive environment, including the loss of the R&D tax credit, and witnesses said the absence of tax incentives has made it harder to keep companies and jobs in the state. The second panel featured company representatives from Lyca Biosystems, Intuitive, Saravia Neurosciences, and Newman. Dr. Monroe described digital pathology as a way to digitize tissue slides, improve access to subspecialty review, and enable AI-assisted diagnosis, especially for cancer care and rural areas. Intuitive highlighted robotic-assisted surgery, including the da Vinci system and the Ion bronchoscopy platform, and said its technologies improve precision, reduce complications, and support clinician-led care. Saravia Neurosciences presented an early-stage neurotechnology for dementia that uses MRI-guided transcranial magnetic stimulation and AI-driven personalization, and argued California needs a state translational fund to bridge the gap between discovery and commercialization. Newman, a startup working on home diagnostics, said California’s permitting, zoning, and manufacturing rules make it difficult to scale advanced manufacturing locally and urged streamlining, reduced red tape, and incentives to keep manufacturing jobs in-state. Committee members again focused on tax credits and asked how the state could better support manufacturing, translational funding, and the retention of high-paying MedTech jobs.

Transcript Highlights:

• technologies that not only diagnose disease, but also enable the production and the development of medicines
• your blood drawn, those types of tests fall into the clinical pathology branch, also known as lab medicine
• the original machine learning-enabled Ion technology, which uses the patient's own scans to map a precise
• to use the ultra-thin catheter you see there to take a precise biopsy without excessive trauma to the
• So really in our $4.2 trillion economy in the state, this is actually a precision instrument.

Keywords: 988, house, all

Summary: The Assembly Select Committee on Biotechnology and Medical Technology held a hearing on California’s medical technology landscape, with opening remarks emphasizing the state’s large life sciences sector and the committee’s interest in understanding MedTech’s economic and policy impacts. The first panel featured Greg Thiel of the Biomedical Manufacturing Network and John Wagner of AdvaMed, who distinguished MedTech from biopharma as more hardware- and manufacturing-oriented, with shorter development cycles, more incremental innovation, and a broader base of middle-skill jobs tied to local supply chains, community colleges, and manufacturing space. They highlighted California clusters in places like Fremont, Irvine, Carlsbad, and Silicon Valley, and cited examples such as Penumbra and Varying Medical Systems to illustrate the importance of infrastructure, land use, and reshoring. Wagner also outlined the FDA’s device classification system and argued that medical devices, including AI-enabled devices, are already heavily regulated federally and should generally be exempt from broader state rules that could create a patchwork of requirements. Committee members asked about cybersecurity, AI, workforce development, supply chain disruptions, trade competitiveness, and the effects of federal NIH funding cuts. The witnesses said cybersecurity is part of FDA review, though they did not have all details on hand, and stressed that AI in MedTech is used in diagnosis, monitoring, treatment, and operational efficiency under FDA oversight. They said California should focus on workforce training in AI, robotics maintenance, quality control, and manufacturing, while also rebuilding local supply chains as reliance on overseas components becomes less reliable and more expensive. Members also raised concerns about the loss of the state R&D tax credit and whether California is losing startups to other states; the witnesses said the lack of incentives and high regulatory costs can push companies elsewhere, and that MedTech is less dependent than biopharma on NIH-style nondilutive funding but still benefits from supportive policy. The panel also discussed FemTech as a growing and active area for acquisition and investment. A second panel included Dr. Rob Monroe of Lyca Biosystems, Emily Sams of Intuitive, Ida Garakhani Good of Saravia Neurosciences, and Lucas Springer of Newman. Monroe described digital pathology as a way to digitize glass slides, improve access to subspecialty review, reduce diagnostic delays and errors, and enable AI-assisted analysis, while noting adoption remains low because of infrastructure costs and lack of reimbursement. Sams described Intuitive’s robotic-assisted surgery systems, including da Vinci and the Ion bronchoscopy platform, emphasizing that the technology is surgeon-controlled, improves precision and recovery, and is supported by extensive clinical evidence; she said AI and machine learning are being integrated to improve outcomes and workflow, but clinicians remain in the loop. Good presented Saravia’s MRI-guided transcranial magnetic stimulation approach for dementia, arguing that MedTech’s biggest challenge is the “translational” gap between promising science and market adoption; she urged the state to create a direct, non-dilutive translational fund to help early-stage companies bridge prototype-to-clinic milestones. Springer, speaking for Newman, said California’s ecosystem is ideal for R&D but too difficult for manufacturing because of permitting, zoning, and regulatory complexity, and he called for streamlined permitting and incentives to keep advanced manufacturing jobs in-state. Committee members again pressed on the R&D tax credit, advanced manufacturing incentives, and whether AI could replace human review; witnesses said AI should augment, not replace, trained professionals, and that pathologists and clinicians remain responsible for final decisions.

Transcript Highlights:

• that is you can go to the grocery store or to the pharmacy or to CVS and buy an over-the-counter medicine
• to think that they would be responsible when they go to the store and buy this over-the-counter medicine
• , just as they would with their prescription medicine, that they would take it as prescribed, but that's
• And that's precisely what happened here.
• And that's precisely what happened here.

Summary: The committee heard and approved several bills. CS for CS for CS SB 138, Trenton’s Law, would broaden DUI and boating-under-the-influence laws to cover any impairing substance, increase penalties for refusal to submit to breath or urine testing, allow blood warrants in misdemeanor DUI/BUI cases, enhance penalties for DUI with death or vehicular homicide involving prior convictions, and authorize DUI diversion programs. Supporters included law enforcement and prosecutors, who said the bill addresses gaps involving over-the-counter drugs and refusal cases; the Florida Association of Criminal Defense Lawyers raised concerns about the breadth of the “any impairing substance” language and record consequences for first refusals. The bill was reported favorably. The committee also reported favorably SB 400, which removes the repeal date from Florida’s Interstate Compact on Educational Opportunities for Military Children, and CS for SB 102, which creates a workforce credentialing program for exceptional student education students, especially those with autism, to earn badges for job skills and safety-related competencies. SB 102 drew questions about fiscal impact and teacher training, with supporters emphasizing workforce readiness and parent involvement while some members raised concerns about costs and implementation. SB 130, which updates compensation for wrongfully incarcerated people found factually innocent, was also reported favorably after supporters argued Florida’s current law is too restrictive and too few exonerees have been compensated. The committee then approved CS for CS for SB 296, which repeals the statewide mandate for later middle and high school start times and returns the decision to local districts, while requiring districts to document their analysis of sleep, safety, transportation, and other impacts. An amendment added a reporting requirement to show how districts considered later start times and any unintended consequences. The bill drew broad support from school officials and education groups, with members noting transportation and extracurricular challenges. Finally, SB 234, dealing with criminal offenses against law enforcement officers, was reported favorably after debate over whether the bill should retain “good faith” language and how it would affect defenses and officer accountability. The committee also passed CS for SB 274, designating a portion of International Drive as Harris Rosen Way and adding a memorial designation for the late Senator Geraldine Thompson near the Wells Built Museum; members praised both honorees and the bill was reported favorably. The committee adjourned after recording one member’s request to be shown voting yes on the first bill.

Transcript Highlights:

• We are happy to be one of the first HBCUs to have a program in medicinal cannabis.
• doing very well, but that is because you have plant soil science, animal science, pre-veterinary medicine
• When we went to visit USDA, number one on the list—and I had to research to understand precision nutrition—and
• When we went to visit USDA, number one on the list, and I had to research to understand precision nutrition
• AI and precision agriculture is really important right now.

Summary: The House Committee on Agriculture, Forestry, Aquaculture, and Rural Development met with a quorum, adopted the minutes from its October 3, 2024 meeting, and Chairwoman Butler noted that HCR 82 would be voluntarily deferred in favor of continuing work on HCR 77 related to a pilot program for landscaping and crawfishing. The committee then considered HCR 205, which urges the USDA to use its Commodity Procurement Program to purchase domestic Louisiana shrimp. Representative Kerner and Commissioner Mike Strain described the shrimp industry’s low prices, full cold storage, and the need for urgent federal action to support shrimpers and move product into schools, nursing homes, and food banks. Members discussed domestic sourcing rules, enforcement against imported seafood, and marketing challenges; HCR 205 was reported favorably without objection. The committee also took up HCR 188, which memorializes Congress to oppose any federal farm bill provision that could negatively affect the use of hunting dogs. Chairwoman Butler and Commissioner Strain explained that the concern centered on vague language in a farm bill section that could be interpreted to restrict hunting dogs used for tracking or field trials. Members agreed the language should be removed if it remained in the bill, and HCR 188 was reported favorably without objection. The committee then heard a presentation from Orlando McMeans of the Southern University Ag Center and College of Agriculture, along with Dr. Calvin Walker. They outlined the center’s research, extension, and academic programs, including enrollment growth, dual-enrollment efforts, 1890 scholars, JAG Stars scholarships, beef cattle and aquaculture research, viticulture, precision nutrition, and food access initiatives. They also described major facility projects, including a high-tech meat processing facility, research labs, a vineyard, and a proposed disaster-safe shelter. Members asked about butcher training, cattle genetics, and the shelter’s potential uses, and the committee adjourned after the presentation.

Transcript Highlights:

• that you'll continue to explore some of these issues and try to assure that we're getting this as precise
• . ...you'll continue to explore some of these issues and try to assure that we're getting this as precise
• And so precisely because we don't want to have to try to reach north and to reach to all these other
• From biotechnology to medicine, agriculture, climate, AI, and beyond, California is the global leader
• From biotechnology to medicine, agriculture, climate, AI, and beyond, California is the global leader

Keywords: 987, senate, all

Transcript Highlights:

• medicine and in ways that we can tailor what's best for the patients.
• medicine and in ways that we can tailor what's best for the patients.
• medicine and in ways that we can tailor what's best for the patients.
• medicine and in ways that we can tailor what's best for the patients.
• </c> with with targeted therapy and precision with with targeted therapy and precision medicine<00:20

Keywords: 910, house, all

Summary: The joint hearing covered HB 553 on biomarker testing coverage, HB 556 on colorectal cancer screening access, and later HB 712 on 340B drug pricing. For HB 553, the American Cancer Society Cancer Action Network, patient advocates Natalie Heyman and Susan Hirano, a surgical oncologist, and the American Lung Association strongly supported the bill, arguing that biomarker testing should be covered when ordered by a doctor and guided by current evidence. DHS and several insurers offered comments and requested amendments, with DHS saying it appreciated the intent but wanted changes. The committees then voted to pass HB 553 with amendments, including a House draft and a defective date of July 1, 3000; both the House Health and Human Services and Homelessness committees adopted the recommendation unanimously. For HB 556, testimony focused on closing gaps in colorectal cancer screening, especially for uninsured and underinsured patients who can get stool-based screening but then cannot access follow-up colonoscopies. Community Clinic of Maui, ACS CAN, and the American Cancer Society supported the bill, with ACS CAN urging a program similar to the breast and cervical cancer control program and offering amendments. DHS requested that the program and appropriation not conflict with executive budget priorities, and the committees noted technical amendments, a defective date, a blank appropriation amount, and corrections changing Medicare references to Medicaid. HB 556 was also passed with amendments by both committees. The hearing then moved to HB 712 on 340B drug pricing and contract pharmacies. The Department of Health and the Attorney General’s office expressed concern that the bill would require the state to regulate private commercial activity and said the department lacked the expertise and resources to implement it as written, suggesting it might belong in a different statutory section. In contrast, PhRMA opposed the bill, while Hawaii Pacific Health and Hawaii Island Community Health Center supported it, saying 340B savings are important for hospital services and patient access to low-cost medications, especially where manufacturers have restricted shipments to contract pharmacies. No vote on HB 712 was taken in the portion provided.

Transcript Highlights:

• </c><01:37:35.480><c> County</c> nuts and bolts in yellow medicine County nuts and bolts in yellow medicine
• So the way it works in Yellow Medicine County is a youth gets charged with an offense.
• The way it works in Yellow Medicine County is a youth gets charged with an offense.
• The way it works in Yellow Medicine County is a youth gets charged with an offense.
• Encourage you to come on out and join us in Yellow Medicine County.

Bills: HF1662, HF1224, HF1836, HF1367, HF1168, HF1999, HF1792, HF102, HF2127, HF104

Keywords: veterans, veterans affairs, State Soldiers Assistance Program, Veterans Stable Housing Initiative, MAXIS, human services data, data sharing, eligibility verification, informed consent, private data, benefits coordination, veteran housing, veteran assistance, Department of Human Services, Children Youth and Families, state benefits, federal benefits, privacy, public assistance, foreclosure